 | Up a level |
Studt, J-D; Alberio, L; Angelillo, Anne; Asmis, L M; Fontana, P; Korte, W; Mendez, A; Schmid, P; Stricker, H; Tsakiris, D A; Wuillemin, W A; Nagler, Michael (2017). Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels. Journal of thrombosis and haemostasis, 15(8), pp. 1576-1583. Wiley-Blackwell 10.1111/jth.13747
Nagler, Michael; Ten Cate, H; Kathriner, S; Casutt, M; Bachmann, L M; Wuillemin, W A (2014). Consistency of thromboelastometry analysis under scrutiny: Results of a systematic evaluation within and between analysers. Thrombosis and haemostasis, 111(6), pp. 1161-1166. Schattauer 10.1160/TH13-10-0870
von Känel, R; Vökt, F; Biasiutti, F D; Stauber, S; Wuillemin, W A; Lukas, P S (2012). Relation of psychological distress to the INR in Patients with venous thromboembolism with and without oral anticoagulant therapy. Journal of thrombosis and haemostasis, 10(8), pp. 1547-55. Oxford: Wiley-Blackwell 10.1111/j.1538-7836.2012.04801.x
Asmis, L M; Alberio, L; Angelillo-Scherrer, A; Korte, W; Mendez, A; Reber, G; Seifert, B; Stricker, H; Tsakiris, D A; Wuillemin, W A (2011). Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests A study in 9 Swiss laboratories. Thrombosis research, 129(4), pp. 492-498. Amsterdam: Elsevier 10.1016/j.thromres.2011.06.031
Kremer Hovinga, J A; Zeerleder, S; Kessler, P; Romani de Wit, T; van Mourik, J A; Hack, C E; ten Cate, H; Reitsma, P H; Wuillemin, W A; Lämmle, B (2007). ADAMTS-13, von Willebrand factor and related parameters in severe sepsis and septic shock. Journal of thrombosis and haemostasis, 5(11), pp. 2284-90. Oxford: Blackwell 10.1111/j.1538-7836.2007.02743.x
